UBS Group AG - CYTORI THERAPEUTICS INC ownership

CYTORI THERAPEUTICS INC's ticker is CYTX and the CUSIP is 23283K204. A total of 27 filers reported holding CYTORI THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CYTORI THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$8,000
+300.0%
29,700
+248.4%
0.00%
Q4 2017$2,000
-88.9%
8,525
-82.6%
0.00%
Q3 2017$18,000
+1700.0%
49,069
+5346.1%
0.00%
Q2 2017$1,000
-83.3%
901
-72.6%
0.00%
Q1 2017$6,000
+500.0%
3,284
+238.9%
0.00%
Q4 2016$1,000
-50.0%
9690.0%0.00%
Q3 2016$2,000
-66.7%
969
-64.9%
0.00%
Q2 2016$6,0002,7610.00%
Other shareholders
CYTORI THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 439,679$703,0000.72%
SABBY MANAGEMENT, LLC 1,271,303$2,034,0000.11%
FNY Partners Fund LP 18,471$29,0000.00%
Virtu KCG Holdings LLC 45,730$73,0000.00%
Intellectus Partners, LLC 2,000$3,0000.00%
SIMPLEX TRADING, LLC 24,332$38,0000.00%
UMB Bank, n.a. 12,385$20,0000.00%
Creative Planning 78,111$125,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 46,200$74,0000.00%
IFP Advisors, Inc 67$00.00%
View complete list of CYTORI THERAPEUTICS INC shareholders